China Cord Blood Corporation(CO)- NYSE
  • Aug. 6, 2015, 9:15 AM
    | Aug. 6, 2015, 9:15 AM | 9 Comments
  • Aug. 6, 2015, 8:27 AM
    • Thinly traded micro cap China Cord Blood (NYSE:CO) is up 26% premarket on increased volume in response to its announcement that it received a non-binding acquisition proposal letter from Nanjing Xinjiekou Department Store Co., Ltd. offering to buy the firm at a price no lower than RMB6.0B ($960M), to be paid in cash or a combination of cash and stock.
    • The special committee of the company's board of directors will carefully assess the proposal.
    | Aug. 6, 2015, 8:27 AM | 4 Comments
  • Jul. 6, 2015, 1:11 PM
    • Thinly traded small cap China Cord Blood (CO -15.2%) is down on double normal volume, albeit on turnover of only 612K shares. No particular news accounts for the move. Management has been mulling a bid for the company by Golden Meditech Holdings.
    | Jul. 6, 2015, 1:11 PM | 2 Comments
  • Jul. 6, 2015, 12:49 PM
    | Jul. 6, 2015, 12:49 PM | 2 Comments
  • Jul. 8, 2014, 12:46 PM
    | Jul. 8, 2014, 12:46 PM
  • Jun. 18, 2013, 6:44 PM
    More on China Cord Blood (CO): FQ4 easily beats estimates across the board on a 33% jump in total sales. Accumulated subscriber base rose by 30.1% Y/Y. Gross margin also rose to 79.8%, from 76.6%. Shares +3.4% AH.
    | Jun. 18, 2013, 6:44 PM
  • Jun. 18, 2013, 5:48 PM
    After-hours top gainers, as of 5:15 p.m.: CO +6%. ADBE +4%. OPK +3%. MY +3%. GEVO +2%.
    After-hours top losers: TTEK -12%. POOL -7%. MGI -5%. AAWW -4%. CROX -3%.
    | Jun. 18, 2013, 5:48 PM | 1 Comment
  • Jun. 18, 2013, 4:14 PM
    China Cord Blood (CO): FQ4 EPS of $0.05 beats by $0.03. Revenue of $21.4M beats by $4.81M. Shares +8.9% AH. (PR)
    | Jun. 18, 2013, 4:14 PM
  • Apr. 12, 2012, 9:39 AM
    KKR will invest $65M in China Cord Blood (CO +22.2%), the country’s largest operator of services for umbilical cord blood that is rich in stem cells, to capitalize on China’s fast growing healthcare services industry. As share prices of U.S.-listed Chinese companies take a beating, some PE firms sniff opportunities.
    | Apr. 12, 2012, 9:39 AM
Company Description
China Cord Blood Corp. engages in the provision of cord blood banking services. It provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies such as cord blood transplants.... More
Sector: Healthcare
Industry: Medical Laboratories & Research
Country: United States